Details
-
Change Request
-
Resolution: Persuasive
-
Highest
-
Adverse Event Clinical Research (FHIR)
-
1.0.0-ballot [deprecated]
-
Biomedical Research & Regulation
-
Adverse Event Seriousness Criteria [deprecated]
-
-
Peter Bomberg / Rebecca Baker : 16 - 0 - 2
-
Clarification
-
Non-substantive
Description
"TBD" in description of Extension: Criteria reviewed in determining serious adverse event
should TBD be removed or descitption edited?
Attachments
Issue Links
- is voted on by
-
BALLOT-51639 Affirmative - Gay Dolin : 2023-Sep-FHIR IG AECR R1 STU
- Balloted